First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA.

Martin  Reck

Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis

Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech

Tudor-Eliade  Ciuleanu

Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Ipsen; Janssen; MSD; Pfizer; Roche; Sanofi; SERVIER

Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Ipsen; Janssen; MSD; Pfizer; Roche; Sanofi; SERVIER

Manuel  Cobo

No Relationships to Disclose

Michael  Schenker

Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer/EMD Serono; Regeneron; Roche

Travel, Accommodations, Expenses - Bristol Myers Squibb

Bogdan  Zurawski

No Relationships to Disclose

Juliana  Janoski de Menezes

No Relationships to Disclose

Eduardo  Richardet

No Relationships to Disclose

Jaafar  Bennouna

Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; SERVIER

Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; SERVIER

Research Funding - AstraZeneca

Travel, Accommodations, Expenses - AstraZeneca; Roche

Enriqueta  Felip

Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Takeda

Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; Novartis; PeerVoice; Pfizer; Prime Oncology; Roche; Springer; Takeda; touchIME

Research Funding - EMD Serono (Inst); Merck (Inst)

Other Relationship - GRÍFOLS

Oscar  Juan-Vidal

Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech

Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche/Genentech; Takeda

Speakers' Bureau - Roche/Genentech

Research Funding - AstraZeneca Spain

Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech

Aurella  Alexandru

Consulting or Advisory Role - Boehringer Ingelheim; Roche

Speakers' Bureau - Bristol-Myers Squibb; Novartis; Sandoz

Expert Testimony - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Sanofi

Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Sanofi

Hiroshi  Sakai

Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical

Research Funding - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Merck KGaA; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical

Arnaud  Scherpereel

Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche

Speakers' Bureau - AstraZeneca

Research Funding - Bristol-Myers Squibb (Inst)

Travel, Accommodations, Expenses - MSD Oncology; Roche

Shun  Lu

Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; Menarini; Pfizer; PrIME Oncology; Roche; Simcere; Yuhan; Zai Lab

Speakers' Bureau - AstraZeneca; Hansoh; Hengrui Therapeutics; Roche

Research Funding - AstraZeneca; BMS; Hansoh; HenRui; Hutchison MediPharma; Roche

Luis G.  Paz-Ares

Leadership - ALTUM Sequencing; Genomica

Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda

Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech

Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda

Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)

David Paul  Carbone

Employment - James Cancer Center

Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc

Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; GlaxoSmithKline; Helsinn Therapeutics; Incyte; Inivata; Inovio Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Loxo; Merck; Novartis; Pfizer; Takeda

Research Funding - Bristol-Myers Squibb

Arteid  Memaj

Employment - Bristol-Myers Squibb

Stock and Other Ownership Interests  - Bristol-Myers Squibb

Sathiya  Marimuthu

Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Hutchison MediPharma (I)

Stock and Other Ownership Interests  - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Hutchison MediPharma (I)

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb (I)

Phuong  Tran

Employment - Bristol-Myers Squibb

Stock and Other Ownership Interests  - Bristol-Myers Squibb

Tom  John

Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech

Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Ignyta; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech

Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Roche